is nausea a side effect of semaglutide Comparative safety and side effects of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management GLP-1 nausea: How to handle

Is Cagrilintide FDA-approved

Follow-Up Time GLP-1Ra users had a median follow-up of 523 days (interquartile range 847 days) with a mean follow-up of 750.0 days (standard deviation 735.5 days)

The primary source of SCFAs is non-digestible host dietary fiber that is fermented by the gut microbiota

Among patients without CKD, minimal increases in serum creatinine were observed for patients on a GLP-1 compared to those who were not prescribed a GLP-1: 0.01 mg/dL for semaglutide, 0.01 mg/dL for liraglutide, and 0.02 mg/dL for tirzepatide

Initially designed to manage type 2 diabetes, Semaglutide has also shown remarkable success in helping people shed those pesky pounds

This reduces the risk of hypoglycemia compared to some other diabetes medications, though this risk increases when combined with insulin or sulfonylureas